Tag

Biogen

3 stories

Biogen Paid $5.6B for Apellis; Filing Confirms Deal Terms

Biogen paid $5.6B for Apellis, and a new SEC filing confirmed the deal details CEO Chris Viehbacher has been engineering: a company that doesn't grow on…

Deals Apr 6, 2026

Anthropic Drops $400M on Six-Person Drug Discovery Startup

Anthropic acquires six-person AI biotech Coefficient Bio for $400M in stock — $66M per employee for a company founded in 2025 with no public product.

Deals Apr 5, 2026

Biogen Drops $5.6B for Apellis at 140% Premium, Shares Fall

Biogen acquires Apellis for $5.6B at a near 140% premium, adding Syfovre and Empaveli to offset a fading MS franchise ahead of pharma's patent cliff.